NCT03465683

Brief Summary

The aim of this research project is to investigate the transmission of ESBL-producing Enterobacteriaceae on both, the level of bacterial strains and mobile genetic elements, and to determine the source of hospital-acquired infections.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Mar 2017Dec 2026

Study Start

First participant enrolled

March 1, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

March 1, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 14, 2018

Completed
8.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

9.8 years

First QC Date

March 1, 2018

Last Update Submit

November 14, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infection/colonization proportion

    The proportion of infection/colonization with genetically related isolates of ESBL-producing Enterobacteriaceae (primary outcome) of the overall infection/colonization rate will be determined and stratified for both, in and outpatient setting for species and time periods

    through study completion, an average of 45months

Interventions

Data and biological sample collection

Eligibility Criteria

Age1 Year+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

out and inpatients from University Hospital Basle

You may qualify if:

  • aged above 1 year
  • proven ESBL-PE carriage from any specimens obtained by routine clinical practice out and inpatients from University Hospital Basle from January 1st until December 31st 2019

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Switzerland, Division of Infecteous Disease and Hospital Epidemiology

Basel, 4031, Switzerland

RECRUITING

Related Publications (1)

  • Aguilar-Bultet L, Bagutti C, Egli A, Alt M, Maurer Pekerman L, Schindler R, Furger R, Eichenberger L, Roloff T, Steffen I, Huebner P, Stadler T, Tschudin-Sutter S. Identification of a Cluster of Extended-spectrum Beta-Lactamase-Producing Klebsiella pneumoniae Sequence Type 101 Isolated From Food and Humans. Clin Infect Dis. 2021 Jul 15;73(2):332-335. doi: 10.1093/cid/ciaa1164.

Biospecimen

Retention: SAMPLES WITH DNA

Enterobacteriaceae

MeSH Terms

Conditions

Cross Infection

Condition Hierarchy (Ancestors)

InfectionsIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sarah Tschudin-Sutter, PD MD

    Division of Infectious Disease and Hopital Epidemiology, University Hospital Basle

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sarah Tschudin-Sutter, PD MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2018

First Posted

March 14, 2018

Study Start

March 1, 2017

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

November 17, 2025

Record last verified: 2025-11

Locations